Evandro D Bezerra

10PUBLICATIONS
124CO-AUTHORS
Molecular targetsHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Gene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jul 14, 2026
Safety and Clinical Outcomes of a First-in-Human Trial of Point-of-Care Manufactured Trispecific CAR T Cells Targeting CD19, CD20, and CD22.

|Oct 06, 2025
CAR HEMATOTOX independently predicts outcomes after CD19 CAR-T therapy for acute lymphoblastic leukemia.

Yannis K Valtis, Chenyu Lin, David Nemirovsky

|Oct 22, 2024
Siltuximab for chimeric antigen receptor T-cell therapy-related CRS and ICANS: a multicenter retrospective analysis.

Amneet Bajwa, Qiuhong Zhao, Marcus Geer

|Apr 12, 2024
Postinfusion PD-1+ CD8+ CAR T cells identify patients responsive to CD19 CAR T-cell therapy in non-Hodgkin lymphoma.

Nathan Denlinger, No-Joon Song, Xiaoli Zhang

|Oct 25, 2023
CD19 occupancy with tafasitamab increases therapeutic index of CART19 cell therapy and diminishes severity of CRS.

R Leo Sakemura, Claudia Manriquez Roman, Paulina Horvei

|Jun 28, 2023
AXL Inhibition Improves the Antitumor Activity of Chimeric Antigen Receptor T Cells.

R Leo Sakemura, Mehrdad Hefazi, Michelle J Cox

Pageof 2

Frequent Collaborators

3 joint publications

Nathan Denlinger

3 joint publications

Claudia Manriquez Roman

3 joint publications

Reona Sakemura

3 joint publications

Lionel Aurelien Kankeu Fonkoua